These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 33185121)

  • 1. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study.
    Bie AKL; Brodersen J
    Scand J Prim Health Care; 2018 Sep; 36(3):262-271. PubMed ID: 30238859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 5. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT).
    Lim TZ; Lau J; Wong GJ; Tan LY; Chang YJ; Natarajan K; Yi H; Wong ML; Tan KK
    Cancer Med; 2021 Nov; 10(21):7735-7746. PubMed ID: 34519182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPs' perspectives on colorectal cancer screening and their potential influence on FIT-positive patients: an exploratory qualitative study from a Dutch context.
    Bertels L; van der Heijden S; Hoogsteyns M; Dekker E; van Asselt K; van Weert H; Knottnerus B
    BJGP Open; 2019 Apr; 3(1):bjgpopen18X101631. PubMed ID: 31049411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme?
    Hoeck S; van de Veerdonk W; De Brabander I
    Eur J Cancer Prev; 2020 Mar; 29(2):119-126. PubMed ID: 31724969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A digital intake tool to avert outpatient visits in a FIT-based colorectal cancer screening population: study protocol of a multicentre, prospective non-randomized trial - the DIT-trial.
    Marijnissen FE; de Jonge PJF; Erler NS; Ismail SY; Lansdorp-Vogelaar I; Spaander MCW
    BMC Gastroenterol; 2024 Jan; 24(1):38. PubMed ID: 38238726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
    Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
    Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The populations attitudes to colorectal cancer screening in the Czech Republic].
    Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
    Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
    J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests.
    Green BB; BlueSpruce J; Tuzzio L; Vernon SW; Aubree Shay L; Catz SL
    BMC Public Health; 2017 May; 17(1):531. PubMed ID: 28558663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonoscopy-Related Mortality in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
    Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Dekker E; Nagtegaal ID; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I; van Leerdam ME
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1418-1425. PubMed ID: 32777553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
    Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
    BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 38.